Clinical Trials Browser

INDUSTRY × tanezumab × Tumor-Agnostic × Clear all

NCT00545129 2021-06-18

A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone

Phase 2 Completed

59 enrolled 32 charts

Neoplasm Metastasis